Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Mitoxantrona")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 762

  • Page / 31
Export

Selection :

  • and

Effect of mitoxantrone on MRI in progressive MS : Results of the MIMS trialKRAPF, H; MORRISSEY, S. P; ZENKER, O et al.Neurology. 2005, Vol 65, Num 5, pp 690-695, issn 0028-3878, 6 p.Article

Mechanism of action of mitoxantroneFOX, Edward J.Neurology. 2004, Vol 63, Num 12, pp S15-S18, issn 0028-3878, SUP6Conference Paper

FOUR NEW CASES OF THERAPY-RELATED ACUTE PROMYELOCYTIC LEUKEMIA AFTER MITOXANTRONEBOSCA, I; PASCUAL, A. M; CASANOVA, B et al.Neurology. 2008, Vol 71, Num 6, pp 457-458, issn 0028-3878, 2 p.Article

Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MSKINGWELL, E; KOCH, M; LEUNG, B et al.Neurology. 2010, Vol 74, Num 22, pp 1822-1826, issn 0028-3878, 5 p.Article

Mitoxantrone and cytotoxic drugs' mechanisms of actionVOLLMER, Timothy; STEWART, Thomas; BAXTER, Nancy et al.Neurology. 2010, Vol 74, Num 1, issn 0028-3878, S41-S46, SUP1Conference Paper

Mitoxantrone in the treatment of acute myelogenous leukemia : a reviewTHOMAS, X; ARCHIMBAUD, E.Hematology and cell therapy (Print). 1997, Vol 39, Num 4, pp 163-174, issn 1269-3286Article

Multidimensional protein identification technology analysis highlights mitoxantrone-induced expression modulations in the primary prostate cancer cell proteomeSYMES, Juliane; EVANGELOU, Andreas; IGNATCHENKO, Alex et al.Proteomics. Clinical applications (Print). 2009, Vol 3, Num 3, pp 347-358, issn 1862-8346, 12 p.Article

Chromium(VI) but Not Chromium(III) Species Decrease Mitoxantrone Affinity to DNANOWICKA, Anna M; STOJEK, Zbigniew; HEPEL, Maria et al.The Journal of physical chemistry. B. 2013, Vol 117, Num 4, pp 1021-1030, issn 1520-6106, 10 p.Article

Mitoxantrone for multiple sclerosis in clinical practiceRIZVI, Syed A; ZWIBEL, Howard; FOX, Edward J et al.Neurology. 2004, Vol 63, Num 12, pp S25-S27, issn 0028-3878, SUP6Conference Paper

Identification of Novel Antipoxviral Agents : Mitoxantrone Inhibits Vaccinia Virus Replication by Blocking Virion AssemblyLIANG DENG; PEIHONG DAI; CIRO, Anthony et al.Journal of virology. 2007, Vol 81, Num 24, pp 13392-13402, issn 0022-538X, 11 p.Article

Review of mitoxantrone in the treatment of multiple sclerosisJEFFERY, Douglas R; HERNDON, Robert.Neurology. 2004, Vol 63, Num 12, pp S19-S24, issn 0028-3878, SUP6Conference Paper

Leucémie après mitoxantrone = Leukemia after mitoxantroneLa Revue Prescrire. 2001, Vol 21, Num 214, issn 0247-7750, p. 122Article

Mitoxantrone-related acute leukemia in MS: An open or closed book?CHAN, Andrew; LO-COCO, Francesco.Neurology. 2013, Vol 80, Num 16, pp 1529-1533, issn 0028-3878, 5 p.Article

Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cellsWICHERT, Anke; STEGE, Alexandra; MIDORIKAWA, Yutaka et al.Oncogene (Basingstoke). 2004, Vol 23, Num 4, pp 945-955, issn 0950-9232, 11 p.Article

Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activityADLAKHA-HUTCHEON, G; BALLY, M. B; SHEW, C. R et al.Nature biotechnology. 1999, Vol 17, Num 8, pp 775-779, issn 1087-0156Article

Chemotherapeutic inhibitors in the treatment of prostate cancerDESHMUKH, Rahul R; SCHMITT, Sara M; HWANG, Clara et al.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 1, pp 11-22, issn 1465-6566, 12 p.Article

Cumulative Mitoxantrone-Induced Haematological and Hepatic Adverse Effects in a Subchronic In vivo StudyROSSATO, Luciana G; COSTA, Vera M; DALLEGRAVE, Eliane et al.Basic & clinical pharmacology & toxicology (Print). 2014, Vol 114, Num 3, pp 254-262, issn 1742-7835, 9 p.Article

Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosisAXELSSON, Markus; MALMESTRÖM, Clas; GUNNARSSON, Martin et al.Multiple sclerosis. 2014, Vol 20, Num 1, pp 43-50, issn 1352-4585, 8 p.Article

High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B-cell lymphoma in first relapse: results of the R-NIMP GOELAMS studyGYAN, Emmanuel; DAMOTTE, Diane; MAISONNEUVE, Hervé et al.British journal of haematology. 2013, Vol 162, Num 2, pp 240-249, issn 0007-1048, 10 p.Article

High-Dose Cytarabine Consolidation With or Without Additional Amsacrine and Mitoxantrone in Acute Myeloid Leukemia: Results of the Prospective Randomized AML2003 TrialSCHAICH, Markus; PARMENTIER, Stefani; EINSELE, Hermann et al.Journal of clinical oncology. 2013, Vol 31, Num 17, pp 2094-2102, issn 0732-183X, 9 p.Article

Treatment of Adults With Acute Lymphoblastic Leukemia: Do the Specifics of the Regimen Matter?: Results From a Prospective Randomized TrialLAMANNA, Nicole; HEFFNER, Leonard T; WEISS, Mark A et al.Cancer. 2013, Vol 119, Num 6, pp 1186-1194, issn 0008-543X, 9 p.Article

Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesisALBERTSSON, Per; LENNERNÄS, B. O; NORRBY, Klas et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2012, Vol 120, Num 2, pp 147-156, issn 0903-4641, 10 p.Article

Oleic acid decreases BCRP mediated efflux of mitoxantrone in Caco-2 cell monolayersASPENSTRÖM-FAGERLUND, Bitte; TALLKVIST, Jonas; ILBÄCK, Nils-Gunnar et al.Food and chemical toxicology. 2012, Vol 50, Num 10, pp 3635-3645, issn 0278-6915, 11 p.Article

Treatment of experimental extravasation of amrubicin, liposomal doxorubicin, and mitoxantrone with dexrazoxaneLANGER, Seppo W; THOUGAARD, Annemette V; SEHESTED, Maxwell et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 2, pp 573-576, issn 0344-5704, 4 p.Article

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyMARRIOTT, James J; MIYASAKI, Janis M; GRONSETH, Gary et al.Neurology. 2010, Vol 74, Num 18, pp 1463-1470, issn 0028-3878, 8 p.Article

  • Page / 31